Genetic polymorphisms in the folate pathway are associated with methotrexate efficacy and adverse effects in Juvenile Idiopathic Arthritis

被引：0
|
作者：
Heijstek, Marloes W. [1 ]
Wulffraat, Nico M. [1 ]
Eken, Yusuf [1 ]
Pluijm, Saskia M. F. [2 ]
Rademaker, Karin M. A. [1 ]
de Jonge, Robert [2 ]
机构：
[1] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Utrecht, Netherlands
[2] Erasmus MC, Rotterdam, Netherlands
来源：
ARTHRITIS AND RHEUMATISM | 2008年 / 58卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S499 / S499
页数：1
相关论文
共 50 条
  • [41] Common polymorphisms in the folate pathway predict efficacy of combination regimens containing methotrexate and sulfasalazine in early rheumatoid arthritis
    James, Heather M.
    Gillis, David
    Hissaria, Pravin
    Lester, Susan
    Somogyi, Andrew A.
    Cleland, Leslie G.
    Proudman, Susanna M.
    JOURNAL OF RHEUMATOLOGY, 2008, 35 (04) : 562 - 571
  • [42] Methotrexate and chronic uveitis associated with juvenile idiopathic arthritis - Reply
    Foeldvari, I
    Wierk, A
    JOURNAL OF RHEUMATOLOGY, 2006, 33 (01) : 198 - 198
  • [43] Single nucleotide polymorphisms in genes coding for folate pathway enzymes are determinants for methotrexate efficacy in early rheumatoid arthritis
    Wessels, JAM
    de Vries-Bouwstra, JK
    Heijmans, BT
    Goekoop-Ruiterman, YPM
    Allaart, CF
    Kerstens, PJ
    van Zeben, D
    Breedveld, FC
    Dijkmans, BAC
    Huizinga, TWJ
    Guchelaar, HJ
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S351 - S352
  • [44] Folate Usage in Methotrexate - Treated Juvenile Idiopathic Arthritis Patients Is Inconsistent and Highly Variable
    Amarilyo, Gil
    Rullo, Ornella J.
    McCurdy, Deborah K.
    Woo, Jennifer M. P.
    Furst, De
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S502 - S502
  • [45] MTHFR polymorphism and red cell folate levels are not useful as biomarkers of methotrexate efficacy and toxicity in children with juvenile idiopathic arthritis
    J Tuková
    M Hroch
    P Doležalová
    Pediatric Rheumatology, 6 (Suppl 1)
  • [46] Efficacy of folinic acid in reducing methotrexate toxicity in juvenile idiopathic arthritis
    Ravelli, A
    Migliavacca, D
    Viola, S
    Ruperto, N
    Pistorio, A
    Martini, A
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1999, 17 (05) : 625 - 627
  • [47] Efficacy of oral versus subcutaneous methotrexate in children with juvenile idiopathic arthritis
    N Tzaribachev
    S Hahn
    M Eichner
    J Schedel
    A Brandt
    J Kuemmerle-Deschner
    Pediatric Rheumatology, 6 (Suppl 1)
  • [48] Use of methotrexate in juvenile idiopathic arthritis
    Ramanan, AV
    Whitworth, P
    Baildam, EM
    ARCHIVES OF DISEASE IN CHILDHOOD, 2003, 88 (03) : 197 - 200
  • [49] Methotrexate in the therapy of juvenile idiopathic arthritis
    Holzinger, D.
    Frosch, M.
    Foell, D.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2010, 69 (06): : 496 - +
  • [50] Methotrexate in the treatment of juvenile idiopathic arthritis
    Seeliger, S
    Niehues, T
    Harms, E
    Frosch, M
    Roth, J
    MONATSSCHRIFT KINDERHEILKUNDE, 2002, 150 (04) : 452 - 459
12345